DHA sbir direct to PH II medical R & D contract awarded from proposal no.-H2D-0119 for "development for shockdefender against hemorrhagic shock"
Ended Definitive Contract Awarded Last action
- Contract number
- HT942523C0067
- Awardee
-
Zymeron Corporation UEI GAMMMRQ6QMN1
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $2,999,999
Award facts
- Opportunity
-
- HQ003420RBDST Solicitation number
- Contract value 100% obligated
- $2,999,998.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27709, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $2,999,999 |
About this award
This is a $2,999,998.63 Firm Fixed Price SBIR Direct to Phase II contract awarded by the Defense Health Agency (DHA) to Zymeron Corporation, a minority-owned small business located in Research Triangle Park, North Carolina. The contract is for the "Development for ShockDefender Against Hemorrhagic Shock" and was awarded from Proposal H2D-0119 under the DHA's Small Business Innovation Research (SBIR) program. The contract has a period of performance through January 14, 2026. Zymeron Corporation is a biotechnology company specializing in innovative medical research and development solutions for federal agencies, and this award demonstrates their expertise in developing advanced medical technologies, particularly in the areas of hemorrhagic shock treatments and other critical healthcare challenges.
Quick answers
Who was awarded contract HT942523C0067?
HT942523C0067 was awarded to Zymeron Corporation by Defense Health Agency (Department of Defense) on September 15, 2023.
How much is contract HT942523C0067 worth?
The government has obligated $2,999,999 on HT942523C0067.
Was contract HT942523C0067 competed?
The extent of competition for HT942523C0067 was full and open competition after exclusion of sources. The government received 5 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award